Paid Clinical Trials in Berkeley, CA
As of August 2026, 56 paid clinical trials are recruiting in Berkeley, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Berkeley offers studies at sites including Alta Bates Summit Medical Center-Herrick Campus for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Amblyopia, Anatomic Stage IIIA Breast Cancer AJCC v8, Aging. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Berkeley
Trials by drug in Berkeley
Filter results
Newly added in Berkeley
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Evaluation of State-Level Sexual and Gender Minority Laws for the Primary Prevention of Sexual and Intimate Partner Violence Among Sexual and Gender Minority Youth in the U.S.
Sperm, Exposure and Endocrine Disruptors
Amplitude Modulation Frequency Comparison in Kilohertz Transcranial Magnetic Perturbation (kTMP) for Chronic Stroke
53 clinical trials
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Performance of Two Daily Disposable Multifocal Contact Lenses
Study of Student Flourishing
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
North American Comfilcon A Clinical Study
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
Kintsugi Voice Device Pivotal Study
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Aphasia Physical EXercise Study: Randomized Trial
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Healthy Lifestyles for Bipolar Disorder
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
Top Research Study Locations in Berkeley
Researchers run research studies in Berkeley, CA at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Alta Bates Summit Medical Center-Herrick Campus | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 20 |
| University of California, Berkeley | Aging, Aphasia, Aphasia Following Cerebral Infarction | 11 |
| Univ. of California- Berkeley | Amblyopia | 3 |
| Alta Bates Summit Medical Center | Large B-cell Lymphoma, Triple Negative Breast Cancer | 2 |
| University of California | Depression, Anxiety, Diet, Mediterranean, Time Restricted Eating | 2 |
| Alta Bates Summit Medical Center Comprehensive Cancer Center | Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma, Non-small Cell Carcinoma | 1 |
| Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 1 |
| Berkeley Outpatient Center | Ductal Carcinoma in Situ | 1 |
| Essential Access | Condom Use | 1 |
| Essential Access Health-Berkeley | Contraception, Women at Risk for Pregnancy | 1 |
| Gravitas Medical, Inc. | Healthy Adults | 1 |
| Kintsugi (Decentralized, Virtual Study) | Depression, Depression Mild, Depression Moderate | 1 |
| Magnetic Tides Inc. | Stroke | 1 |
| Million Marker Wellness Inc. | Fertility, Male Fertility, Sperm Count, Low | 1 |
| Neurobehavioral Systems, Inc. | Aging, Alzheimer Disease, Cognitive Decline | 1 |
| RTI | Adolescent Behavior, Pregnancy Related, Sexually Transmitted Diseases | 1 |
| Sutter Alta Bates | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| U.C. Berkeley Clinical Research Center | Dry Eye, Meibomian Gland Dysfunction | 1 |
| UCSF Cancer Center Berkeley | Breast Cancer | 1 |
| UCSF at Berkeley Outpatient Center | Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases | 1 |
| University Of California, Berkeley Myopia Research Group | Myopia, Myopia Progression | 1 |
| University of Berkeley | Ametropia, Astigmatism, Presbyopia | 1 |
| University of California Berkeley | Bipolar Disorder, Time Restricted Eating | 1 |
| University of California, Berkeley, School of Optometry | Myopia | 1 |
Active & Upcoming Studies in Berkeley (2026)
Recruiting trials in Berkeley grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (26 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Mental health & behavior (3 active studies)
- Kintsugi Voice Device Pivotal Study · Kintsugi Mindful Wellness, Inc.
- Healthy Lifestyles in Bipolar Disorder: Bay Area Study · University of California, Berkeley
Neurology & pain (3 active studies)
HIV / STI (1 active study)
Eye & vision (1 active study)
- Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment · Phase 4 · University of California, Berkeley
Pediatric (1 active study)
Common conditions studied in Berkeley
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Amblyopia (3 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
- Aging (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
- Breast Cancer (2 active studies)
Leading research sponsors in Berkeley
- University of California, Berkeley
- SWOG Cancer Research Network
- NRG Oncology
- National Cancer Institute (NCI)
- Jaeb Center for Health Research
Frequently asked questions
How many paid clinical trials are currently recruiting in Berkeley?
There are approximately 56 recruiting clinical trials in Berkeley, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Berkeley pay participants?
Most recruiting trials in Berkeley compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Berkeley?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Berkeley?
The most common conditions under active study in Berkeley include Anatomic Stage II Breast Cancer AJCC v8 (4), Amblyopia (3), Anatomic Stage IIIA Breast Cancer AJCC v8 (3), Aging (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Berkeley?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Berkeley on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Berkeley?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Berkeley?
Recruiting research sites in Berkeley include Alta Bates Summit Medical Center-Herrick Campus, University of California, Berkeley, Univ. of California- Berkeley, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Berkeley right now?
The largest active categories in Berkeley are Cancer & tumors (26), Mental health & behavior (3), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.